SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C200 - Therapy in Neurology I: Multiple Sclerosis and Headache

Event Time: Thursday April 27, 2017 1:00 pm to 3:00 pm
Topic(s): General Neurology, General Neurology: Overview
Director(s): David Dodick MD, FAAN
Description: Refinement in diagnostic criteria for demyelinating diseases and headache disorders and advancement in therapies have improved the ability of clinicians to accurately diagnose these disorders in clinical practice and provide evidence-based treatments that improve patient outcomes. Through comprehensive overviews, faculty will discuss the application of diagnostic criteria and individualized therapy. This program complements C213: Therapy in Neurology II: Epilepsy and Neuro-oncology, C231: Therapy in Neurology III: Neuromuscular Disease and Neuro-infectious Disease, and C239: Therapy in Neurology IV: Movement Disorders and Cerebrovascular Disease, but covers independent topics.
Completion Message: Participants should be able to distinguish demyelinating diseases from mimics, identify common primary headache disorders, and select appropriate treatments based on evidence and disease severity.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Program Speakers - Tentative

Start/End Time Title Faculty
1:00 PM - 1:45 PM Multiple Sclerosis and Related Autoimmune CNS Disorders Dean Wingerchuk MD, FAAN 
1:45 PM - 2:00 PM Questions and Answers Dean Wingerchuk MD, FAAN 
2:00 PM - 2:45 PM Headache David Dodick MD, FAAN 
2:45 PM - 3:00 PM Questions and Answers David Dodick MD, FAAN 

Disclosures

Speaker Disclosure
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acorda, Allergan, Amgen, Alder, Dr Reddy’s, Merck, Dr Reddy’s, Promius, eNeura, Eli Lilly & Company, Insys therapeutics, Autonomic Technologies, Teva, Xenon, Tonix, Trigemina, Boston Scientific, GBS, Colucid, Zosano, Laydenburg Thalmann, Biocentric, Biohaven, Magellan, Pfizer (Japan), Charleston Laboratories. Royalties: Oxford University Press and Cambridge University Press (Book Royalty). Uptodate – editorial/honoraria. CME companies honoraria/publishing honoraria/royalites: Chameleon Communications, Medscape, WebMD, Academy for Continued Healthcare Learning, Haymarket Medical Education, Miller Medical Communications, Global Scientific Communications, HealthLogix, Academy for Continued Healthcare Learning, Meeting LogiX, Health LogiX, . Dr. Dodick has received compensation for serving on the Board of Directors of . Dr. Dodick holds stock and/or stock options in Nocira, Second Opinion, .

Dean M. Wingerchuk, MD, FAAN Dr. Wingerchuk has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Caladrius and MedImmune. Dr. Wingerchuk has received personal compensation in an editorial capacity for The Neurologist.. Dr. Wingerchuk has received research support from Alexion and TerumoBCT.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C2 Functional Neurologic Disorders I: Movement, Seizures, and Speech Disorders Alberto Espay MD, FAAN
7:00 AM-4:00 PM
C6 Neurology MOC Prep Course Nicholas Johnson MD
9:30 AM-11:30 AM
C8 Emergency Neurology: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room Jose Suarez MD
C12 Functional Neurologic Disorders II: Life Experiences and Management of Functional Disorders Alberto Espay MD, FAAN
12:00 PM-1:00 PM
Navigating the Annual Meeting App Carlayne Jackson MD, FAAN
1:30 PM-3:30 PM
C22 Critical Care Consultations for Neurohospitalists Vanja Douglas MD
4:15 PM-5:30 PM
PL1 Hot Topics Plenary Session

Wednesday April 25, 2018

7:00 AM-9:00 AM
C139 Neurologic Case Studies in Pregnancy Mary O'Neal MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C144 Neurology Update I: Epilepsy, Behavioral Neurology, and Neurologic Infections Ralph Jozefowicz MD, FAAN
C148 LGBTQI Health in Neurology Holly Hinson MD, MCR
3:30 PM-5:30 PM
C160 Neurology Update II: Movement Disorders, Spine Disorders, and Sleep Disorders Ralph Jozefowicz MD, FAAN
C168 CNS Toxicities Neeraj Kumar MD

MEMBER LOG IN

Forgot Password?